SCHEMBL2277873

SCHEMBL2277873

CC(C)(C)OC(=O)c1ccc(Oc2cc(F)cc(F)c2)cc1NC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYGM P11217 2/20 0.44
PYGL P06737 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PPARG P37231 1/20 0.42
PPARD Q03181 1/20 0.42
GPBAR1 Q8TDU6 1/20 0.42
NR1H4 Q96RI1 1/20 0.42
KCNK2 O95069 1/20 0.42
KCNK10 P57789 1/20 0.42
ELANE P08246 1/20 0.42
PRTN3 P24158 1/20 0.42
PGR P06401 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2269139 0.87 CYP2C9 (0.47) PYGMPYGLCYP2C19KDM4EMAPK1
SCHEMBL2267916 0.85 PYGM (0.46) PYGMPYGLCYP1A2CYP2D6TSHR
SCHEMBL2271524 0.85 PYGM (0.56) PYGMPYGLKCNK2KCNK10TDP1
SCHEMBL2274026 0.85 PGR (0.61) PYGMTSHRKDM4EMAPK1HSD17B10
SCHEMBL2269667 0.83 F10 (0.53) PYGMKDM4EPPARGPPARDGPBAR1
SCHEMBL2275398 0.83 SMN1; SMN2 (0.54) PYGMPYGLKDM4ETDP1MEN1
SCHEMBL2269847 0.82 HDAC2 (0.52) KDM4EMAPK1HSD17B10NR1H4PGR
SCHEMBL2270545 0.82 FFAR1 (0.56) PYGMPYGLKDM4EMAPK1MEN1
SCHEMBL2275596 0.82 FABP1 (0.51) PYGMPGRTDP1MEN1KMT2A
SCHEMBL2276220 0.81 L3MBTL1 (0.55) KDM4EMAPK1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 PYGM 1299/4885PYGL 1834/4885CYP1A2 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.